Refining Lung Cancer Screening Criteria in the Era of Value-Based Medicine

In a Perspective on the Research Article by ten Haaf and colleagues, Steven Shapiro discusses the challenges of identifying screening strategies that maximize the number of cancers diagnosed, while minimizing the harms of overdiagnosis and maintaining cost-effectiveness.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PLoS medicine 2017-02, Vol.14 (2), p.e1002226-e1002226
1. Verfasser:	Shapiro, Steven D
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis Big Data Biology and Life Sciences Cancer screening Cost analysis Cost-Benefit Analysis Diagnosis Early Detection of Cancer - economics Economic aspects Forecasts and trends Funding Health care costs Health care policy Humans Lung cancer Mass Screening - economics Medical screening Medicine Medicine and Health Sciences Mortality Patient outcomes People and Places Research and Analysis Methods Smoking Social Sciences
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	In a Perspective on the Research Article by ten Haaf and colleagues, Steven Shapiro discusses the challenges of identifying screening strategies that maximize the number of cancers diagnosed, while minimizing the harms of overdiagnosis and maintaining cost-effectiveness.
ISSN:	1549-1676 1549-1277 1549-1676
DOI:	10.1371/journal.pmed.1002226